Financhill
Back

Smith & Nephew plc Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Sell
50

SNNUF
Smith & Nephew plc

Last Price:
$16.90
Seasonality Move:
-1.71%
Sell
38

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.22
Seasonality Move:
-13.28%
Sell
50
Smith & Nephew plc (SNNUF) is a Sell

Is Smith & Nephew plc a Buy, Sell or Hold?

  • The current Smith & Nephew plc [SNNUF] share price is $16.90. The Score for SNNUF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • SNNUF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.34. The Score for CRNX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SNNUF Stock Price Chart

What is Smith & Nephew plc's stock price today?

  • The Smith & Nephew plc share price today is $16.90
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNNUF is experiencing slight buying pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

SNNUF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.1 Buy
Relative Strength Index (14 RSI): 76.46 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.67 - 16.33) Buy
Bollinger Bands (100): (15.71 - 17.83) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.96 Buy
Relative Strength Index (14 RSI): 66.03 Buy
Chaikin Money Flow: 3428689 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.13 - 49.63) Buy
Bollinger Bands (100): (35.09 - 47.19) Buy

SNNUF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.39 Buy
20-day SMA: 15.61 Buy
50-day SMA: 15.95 Buy
200-day SMA: 15.69 Buy
8-day EMA: 16.01 Buy
20-day EMA: 12.26 Buy
50-day EMA: 6.92 Buy
200-day EMA: 2.1 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.2 Buy
20-day SMA: 48.28 Buy
50-day SMA: 45.42 Buy
200-day SMA: 36 Buy
8-day EMA: 48.68 Buy
20-day EMA: 47.84 Buy
50-day EMA: 45.56 Buy
200-day EMA: 40.15 Buy

Smith & Nephew plc Earnings Growth & SNNUF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

Smith & Nephew plc Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):